Our findings that obesity negatively impacted antitumor immunity via enhanced G-MDSC accumulation and CD8 TIL apoptosis prompted us to ask if these changes impaired immunotherapy outcomes. The gene discussed is CD8A; the disease is obesity due to melanocortin 4 receptor deficiency.